Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jianpi bushen shengyang keli
- Development stage
- Unknown
- Lead developer
- Guangzhou University of Chinese Medicine
- Administration
- Oral
01
Overview
Jianpi Bushen Shengyang Granules is a Traditional Chinese Medicine (TCM) herbal formulation primarily developed for the treatment of cancer-related fatigue (CRF) and syndromes associated with Spleen and Kidney deficiency. The preparation is composed of several botanical extracts, including *Astragalus membranaceus*, *Codonopsis pilosula*, and *Atractylodes macrocephala*, which are traditionally used to tonify Qi and raise Yang energy. Mechanistically, the granules are thought to modulate the immune system, reduce inflammatory cytokine levels (such as IL-6 and TNF-α), and improve mitochondrial function to enhance energy metabolism. It is frequently utilized in integrative oncology settings in China to improve the quality of life and physical stamina of patients undergoing cytotoxic therapies.
- Brand names
- Jianpi Bushen Shengyang Granules
- Other names
- 健脾补肾升阳颗粒Jianpi Bushen Shengyang Keli
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)
Beyond the preview
Go deeper on jianpi bushen shengyang keli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jianpi bushen shengyang keli.